Ajay Chaudhuri MBBS, MRCP(UK),FACE
Ajay Chaudhuri
MBBS, MRCP(UK),FACE
Clinical Professor of Medicine, Chief of Endocrinology
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Endocrinology, Diabetes and Metabolism
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDEducation and Training:
- Medicine, Calcutta University (1987)
Employment:
- Chief of Endocrinology, UBMD-Internal Medicine (2018-present)
- Clinical Professor of Medicine, Diabetes, Endocrinology and Metabolism, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2015-present)
Awards and Honors:
- Top Doctors (2024)
- Top Doctors in America - Buffalo Spree (2020)
- Who's Who in Healthcare - Business First Buffalo (2014)
- Helmsley Award for Best Abstract on Type I Diabetes (2014)
- Outstanding Accreditation Award by SUNY at Buffalo (2012)
Research Expertise:
- anti-inflamatory and anti-thrombotic effect of insulin infusion: Investigating the anti-inflammatory and antithrombotic effect of insulin infusion and glycemic control in acute myocardial infarction and stroke.
- Effec t of GLP-1 receptor agonists on insulin sensitivity: Investigating the effect of GLP-1 receptor agonists on insulin sensitivity, atherogenesis, inflammatory parameters, blood pressure and microvascular complications in patients with type 2 diabetes mellitus.
Grants and Sponsored Research:
- July 2020–July 2021
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study
Spruce Biosciences
Role: Principal Investigator - March 2017–December 2020
Liraglutide Hospital Discharge Trial: A Randomized Controlled Trial Comparing the
Novo Nordisk
Role: Principal Investigator - May 2013–December 2018
Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors AND Adiposity in Type 2 Diabetic Males with Hypogonadotrophic Hypogonadism
AbbVie Incorporated
Role: Co-Investigator - January 2007–December 2012
Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglyceride and Impact on Global Health Outcomes. The goal of this study is to investigate if increasing HDL in subjects with low HDL and cardiovascular disease will result in improv
NIH/NHLBI
Role: Principal Investigator - January 2008–January 2010
Effect of a low dose insulin infusion and normoglycemia in patients with STEMI. The goal of this study was to investigate if lowering glucose with insulin infusion in acute STEMI would lead to reduction in cardiac infarct size. Study was based on the p
Sanofi-Aventis Pharmaceuticals
Role: Principal Investigator - August 2006–August 2007
A 13-week Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Trial Assessing the Safety, Tolerability and Efficacy of AVE0010 in Metformin-Treated Subjects with Type 2 Diabetes Mellitus.
Sanofi-Aventis
Role: Co-Investigator
Journal Articles:
- Ghanim H, Batra M, Green K, Abuaysheh S, Hejna J, Makdissi A, Borowski R, Kuhadiya ND, Chaudhuri A, Dandona P. (2020) Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss. Diabetes Obes Metab (May).
- Ghanim H, Abuaysheh S, Hejna J, Green K, Batra M, Makdissi A, Chaudhuri A, Dandona P. (2020) Dapagliflozin Suppresses Hepcidin And Increases Erythropoiesis. J Clin Endocrinol Metab (Apr), 105(4).
- Ghanim H, Dhindsa S, Batra M, Green K, Abuaysheh S, Kuhadiya ND, Makdissi A, Chaudhuri A, Sandhu S, Dandona P. (2020) Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes. J Clin Endocrinol Metab (Apr), 105(4).
- Dhindsa S, Ghanim H, Green K, Abuaysheh S, Batra M, Makdissi A, Chaudhuri A, Sandhu S, Dandona P. (2019) Acute effects of insulin on skeletal muscle growth and differentiation genes in men with type 2 diabetes. Eur J Endocrinol (Dec), 181(6): 55-59.
- Ghanim H, Dhindsa S, Green K, Abuaysheh S, Batra M, Makdissi A, Chaudhuri A, Dandona P. (2019) Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone. J Endocr Soc (Aug), 3(8): 1617-1630.
- Dandona P, Ghanim H, Chaudhuri A. (2019) Liraglutide and systolic blood pressure. J Clin Hypertens (Greenwich) (Jan), 21(1): 116-117.
- Ghanim H, Dhindsa S, Batra M, Green K, Abuaysheh S, Kuhadiya ND, Makdissi A, Chaudhuri A, Dandona P. (2019) Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth. J Clin Endocrinol Metab (Jan), 104(6): 2094-2102.
- Ghanim H, Dhindsa S, Abuaysheh S, Batra M, Kuhadiya ND, Makdissi A, Chaudhuri A, Dandona P. (2018) Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone. Eur J Endocrinol (Mar), 178(3): 277-283.
- Dandona P, Ghanim H, Chaudhuri A. (2018) Incretins: Beyond type 2 diabetes. Diabetes Obes Metab (Jan), 20 Su: 59-67.
- Dandona P, Ghanim H, Abuaysheh S, Green K, Dhindsa S, Makdissi A, Batra M, Kuhadiya ND, Chaudhuri A. (2018) Exenatide Increases IL-1RA Concentration and Induces Nrf-2‒Keap-1‒Regulated Antioxidant Enzymes: Relevance to β-Cell Function. J Clin Endocrinol Metab (Jan), 103(3): 1180-1187.
- Garg M, Ghanim H, Kuhadiya ND, Green K, Hejna J, Abuaysheh S, Torre B, Batra M, Makdissi A, Chaudhuri A, Dandona P. (2017) Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes. Diabetes Obes Metab (Sep), 19(9): 1306-1311.
- Ghanim H, Green K, Abuaysheh S, Patel R, Batra M, Chaudhuri A, Makdissi A, Kuhadiya ND, Dandona P. (2017) Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients. Atherosclerosis (Aug), 263: 278-286.
- Chaudhuri A, Ghanim H, Makdissi A, Green K, Abuaysheh S, Batra M, D Kuhadiya N, Dandona P. (2017) Exenatide induces an increase in vasodilatory and a decrease in vasoconstrictive mediators. Diabetes Obes Metab (May), 19(5): 729-733.
- Dandona P, Chaudhuri A. (2017) Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician. Int J Clin Pract (May), 71(5).
- Ghanim H, Batra M, Abuaysheh S, Green K, Makdissi A, Kuhadiya ND, Chaudhuri A, Dandona P. (2017) Antiinflammatory and ROS Suppressive Effects of the Addition of Fiber to a High-Fat High-Calorie Meal. J Clin Endocrinol Metab (Mar), 102(3): 858-869.
- Kuhadiya ND, Ghanim H, Mehta A, Garg M, Khan S, Hejna J, Torre B, Makdissi A, Chaudhuri A, Batra M, Dandona P. (2016) Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes. J Clin Endocrinol Metab (Sep), 101(9): 3506-3515.
- Kuhadiya ND, Dhindsa S, Ghanim H, Mehta A, Makdissi A, Batra M, Sandhu S, Hejna J, Green K, Bellini N, Yang M, Chaudhuri A, Dandona P. (2016) Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks. Diabetes Care (Jun), 39(6): 1027-1035.
- Dhindsa S, Ghanim H, Batra M, Kuhadiya ND, Abuaysheh S, Green K, Makdissi A, Chaudhuri A, Dandona P. (2016) Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes. Clin Endocrinol (Oxf) (Jun).
- Chaudhuri A, Ghanim H, Dandona P. (2016) Targeting AMP Kinase in Myeloid Cells to Reduce Atherosclerosis. Diabetes (Jun), 65(6): 1493-1495.
- Dandona P, Kuhadiya ND, Ghanim H, Chaudhuri A. (2016) ADJUNCT THERAPIES IN TYPE 1 DIABETES. Endocr Pract (Feb), 22(2): 277-280.
- Dhindsa S, Ghanim H, Batra M, Kuhadiya ND, Abuaysheh S, Sandhu S, Green K, Makdissi A, Hejna J, Chaudhuri A, Punyanitya M, Dandona P. (2016) Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes. Diabetes Care (Jan), 39(1): 82-91.
- Dandona P, Ghanim H, Abuaysheh S, Green K, Batra M, Dhindsa S, Makdissi A, Patel R, Chaudhuri A. (2015) Decreased insulin secretion and incretin concentrations and increased glucagon concentrations after a high-fat meal when compared with a high-fruit and -fiber meal. Am J Physiol Endocrinol Metab (Feb), 308(3): 185-191.
- Ghanim H, Green K, Abuaysheh S, Batra M, Kuhadiya ND, Patel R, Makdissi A, Dhindsa S, Chaudhuri A, Dandona P. (2015) Suppressive effect of insulin on the gene expression and plasma concentrations of mediators of asthmatic inflammation. J Diabetes Res (Jan), 2015: 202406-202406.
- Dandona P, Chaudhuri A. (2014) Diabetes: Glycaemia and insulin after acute myocardial infarction. Nat Rev Endocrinol (Aug), 10(8): 448-450.
- Dandona P, Ghanim H, Monte SV, Caruana JA, Green K, Abuaysheh S, Lohano T, Schentag J, Dhindsa S, Chaudhuri A. (2014) Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss. Obesity (Silver Spring) (Feb), 22(2): 356-362.
- Dandona P, Ghanim H, Sia CL, Green K, Abuaysheh S, Dhindsa S, Chaudhuri A, Makdissi A. (2014) A mixed anti-inflammatory and pro-inflammatory response associated with a high dose of corticosteroids. Curr Mol Med (Jan), 14(6): 793-801.
- Dandona P, Ghanim H, Green K, Sia CL, Abuaysheh S, Kuhadiya N, Batra M, Dhindsa S, Chaudhuri A, Kuhadiya ND. (2013) Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Am J Physiol Endocrinol Metab (Apr), 304(8): 810-818.
- Chaudhuri A, Dandona P, Fonseca V. (2012) Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab (Sep), 97(9): 3079-3091.
- Makdissi A, Ghanim H, Vora M, Green K, Abuaysheh S, Chaudhuri A, Dhindsa S, Dandona P. (2012) Sitagliptin exerts an antinflammatory action. J Clin Endocrinol Metab (Sep), 97(9): 3333-3341.
- Varanasi A, Patel P, Makdissi A, Dhindsa S, Chaudhuri A, Dandona P. (2012) Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors. Endocr Pract (Mar), 18(2): 140-145.
- Chaudhuri A, Rosenstock J, DiGenio A, Meneghini L, Hollander P, McGill JB, Dandona P, Ilgenfritz J, Riddle M. (2012) Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis. Diabetes Metab Res Rev (Mar), 28(3): 258-267.
- Chaudhuri A, Ghanim H, Vora M, Sia CL, Korzeniewski K, Dhindsa S, Makdissi A, Dandona P. (2012) Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab (Jan), 97(1): 198-207.
- Chaudhuri A, Dandona P. (2011) Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes. Diabetes Obes Metab (Oct), 13(10): 869-879.
- Dhindsa S, Furlanetto R, Vora M, Ghanim H, Chaudhuri A, Dandona P. (2011) Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care (Aug), 34(8): 1854-1859.
- Varanasi A, Bellini N, Rawal D, Vora M, Makdissi A, Dhindsa S, Chaudhuri A, Dandona P. (2011) Liraglutide as additional treatment for type 1 diabetes. Eur J Endocrinol (Jul), 165(1): 77-84.
- Dandona P, Mohamed I, Ghanim H, Sia CL, Dhindsa S, Dandona S, Makdissi A, Chaudhuri A. (2011) Insulin Suppresses the Expression of Amyloid Precursor Protein, Presenilins, and Glycogen Synthase Kinase-3{beta} in Peripheral Blood Mononuclear Cells. J Clin Endocrinol Metab (Jun), 96(6): 1783-1788.
- Varanasi A, Chaudhuri A, Dhindsa S, Arora A, Lohano T, Vora MR, Dandona P. (2011) Durability of effects of exenatide treatment on glycemic control, body weight, systolic blood pressure, C-reactive protein, and triglyceride concentrations. Endocr Pract (Mar), 17(2): 192-200.
- Dandona P, Ghanim H, Bandyopadhyay A, Korzeniewski K, Ling Sia C, Dhindsa S, Chaudhuri A. (2010) Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care (Nov), 33(11): 2416-2423.
- Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P. (2010) An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab (Sep), 95(9): 1-8.
- Dandona P, Chaudhuri A, Ghanim H. (2010) Rosiglitazone, thiazolidinediones and atherosclerosis. Atherosclerosis (Aug), 211(2): 384-385.
- Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P. (2010) Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care (Jun), 33(6): 1186-1192.
- Ghanim H, Korzeniewski K, Sia CL, Abuaysheh S, Lohano T, Chaudhuri A, Dandona P. (2010) Suppressive effect of insulin infusion on chemokines and chemokine receptors. Diabetes Care (May), 33(5): 1103-1108.
- Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, Mohanty P, Viswanathan P, Chaudhuri A, Dandona P. (2010) Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care (May), 33(5): 991-997.
- Dandona P, Ghanim H, Chaudhuri A, Dhindsa S, Kim SS. (2010) Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistance. Exp Mol Med (Apr), 42(4): 245-253.
- Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care (Dec), 32(12): 2281-2287.
- Dandona P, Dhindsa S, Chandel A, Chaudhuri A. (2009) Hypogonadotropic hypogonadism in men with type 2 diabetes. Postgrad Med (May), 121(3): 45-51.
- Dandona P, Chaudhuri A, Ghanim H, Mohanty P. (2009) Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol (Feb), 53(5 Sup): 14-20.
- Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P. (2008) Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med (Dec), 8(8): 816-828.
- Dhindsa S, Upadhyay M, Viswanathan P, Howard S, Chaudhuri A, Dandona P. (2008) Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus. Endocr Pract (Nov), 14(8): 1000-1005.
- Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P. (2008) Testosterone concentration in young patients with diabetes. Diabetes Care (Oct), 31(10): 2013-2017.
- Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S. (2008) Hypogonadotrophic hypogonadism in type 2 diabetes. Aging Male (Sep), 11(3): 107-117.
- Ghanim H, Mohanty P, Deopurkar R, Sia CL, Korzeniewski K, Abuaysheh S, Chaudhuri A, Dandona P. (2008) Acute modulation of toll-like receptors by insulin. Diabetes Care (Sep), 31(9): 1827-1831.
- Dandona P, Chaudhuri A, Ghanim H, Mohanty P. (2008) Use of insulin to improve glycemic control in diabetes mellitus. Cardiovasc Drugs Ther (Jun), 22(3): 241-251.
- Dandona P, Chaudhuri A. (2008) Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?. Nat Clin Pract Cardiovasc Med (May), 5(5): 244-245.
- Dandona P, Ghanim H, Chaudhuri A, Mohanty P. (2008) Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes. J Diabetes Complications (Jan), 22(1): 62-75.
- Chaudhuri A, Miller M, Nesto R, Rosenberg N, Dandona P. (2007) Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target?. Diabetes Care (Dec), 30(12): 3026-3028.
- Chaudhuri A, Janicke D, Wilson M, Ghanim H, Wilding GE, Aljada A, Dandona P. (2007) Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction. Am J Cardiol (Dec), 100(11): 1614-1618.
- Viswanathan P, Chaudhuri A, Bhatia R, Al-Atrash F, Mohanty P, Dandona P. (2007) Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin. Endocr Pract (Sep), 13(5): 444-450.
- Dandona P, Chaudhuri A, Mohanty P, Ghanim H. (2007) Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care (Jul), 10(4): 511-517.
- Dhindsa S, Bhatia V, Dhindsa G, Chaudhuri A, Gollapudi GM, Dandona P. (2007) The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care (Jul), 30(7): 1860-1861.
- Dandona P, Chaudhuri A, Ghanim H, Mohanty P. (2007) Effect of hyperglycemia and insulin in acute coronary syndromes. Am J Cardiol (Jun), 99(11A): 12-18.
- Ghanim H, Mohanty P, Pathak R, Chaudhuri A, Sia CL, Dandona P. (2007) Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care (Jun), 30(6): 1406-1411.
- Dandona P, Chaudhuri A, Ghanim H, Mohanty P. (2007) Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol (Feb), 99(4A): 15-26.
- Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A, Dandona P. (2007) Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia (Feb), 50(2): 278-285.
- Dandona P, Dhindsa S, Ghanim H, Chaudhuri A. (2007) Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens (Jan), 21(1): 20-27.
- Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H, Dandona P. (2006) Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care (Oct), 29(10): 2289-2294.
- Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P. (2006) Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab (Sep), 91(9): 3553-3558.
- Aljada A, Friedman J, Ghanim H, Mohanty P, Hofmeyer D, Chaudhuri A, Dandona P. (2006) Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism (Sep), 55(9): 1177-1185.
- Tomar R, Dhindsa S, Chaudhuri A, Mohanty P, Garg R, Dandona P. (2006) Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care (May), 29(5): 1120-1122.
- Dandona P, Chaudhuri A, Ghanim H, Mohanty P. (2006) Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes. Rev Cardiovasc Med (Jan), 7 Sup: 25-34.
- Dandona P, Chaudhuri A, Ghanim H, Mohanty P. (2006) Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin Thorac Cardiovasc Surg (Jan), 18(4): 293-301.
- Garg R, Chaudhuri A, Munschauer F, Dandona P. (2006) Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke (Jan), 37(1): 267-273.
- Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. (2004) Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab (Nov), 89(11): 5462-5468.
- Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A. (2004) Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab (Oct), 89(10): 5043-5047.
- Dandona P, Aljada A, Chaudhuri A, Mohanty P. (2004) Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord (Aug), 5(3): 189-197.
- Dandona P, Chaudhuri A, Aljada A. (2004) Endothelial dysfunction and hypertension in diabetes mellitus. Med Clin North Am (Jul), 88(4): 911-931.
- Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, Dandona P. (2004) Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr (Apr), 79(4): 682-690.
- Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P. (2004) Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation (Feb), 109(7): 849-854.
- Dandona P, Dhindsa S, Aljada A, Chaudhuri A. (2004) Classical Anti-oxidants (Scavengers) versus Biological Anti-oxidants (Suppressors of ROS Generation): ANovel Way to Explain the Anti-oxidant Paradox. Metab Syndr Relat Disord (Jan), 2(3): 155-159.
- Dandona P, Aljada A, Mohanty P, Ghanim H, Bandyopadhyay A, Chaudhuri A. (2003) Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care (Dec), 26(12): 3310-3314.
- Dandona P, Aljada A, Chaudhuri A. (2003) Vascular reactivity and thiazolidinediones. Am J Med (Dec), 115 S: 81-86.
- Dandona P, Aljada A, Chaudhuri A, Bandyopadhyay A. (2003) The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab (Jun), 88(6): 2422-2429.
- Chaudhuri A, Kanjwal Y, Mohanty P, Rao S. (2003) Absence of insulin-induced vasodilation of internal carotid artery in type 2 diabetes. Metab Syndr Relat Disord (Mar), 1(1): 69-73.
- Perregaux D, Chaudhuri A, Rao S, Airen A, Wilson M, Sung BH, Dandona P. (2000) Brachial vascular reactivity in blacks. Hypertension (Nov), 36(5): 866-871.
- Chaudhuri A, Izzo JL. (2000) Insulin resistance and hypertension in the absence of subcutaneous fat. Rev Cardiovasc Med (Jan), 1(2): 120-124.
- Chaudhuri A, Kanjwal Y, Mohanty P, Rao S, Sung BH, Wilson MF, Dandona P. (1999) Insulin-induced vasodilatation of internal carotid artery. Metabolism (Nov), 48(11): 1470-1473.
- Perregaux D, Chaudhuri A, Mohanty P, Bukhari L, Wilson MF, Sung BH, Dandona P. (1999) Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism (Feb), 48(2): 227-232.
- Chaudhuri A, Tomar R, Mohanty P, Szudzik E, Bandyopadhyay A, Arian M, Thusu K, Dandona P. (1998) The combination of insulin and metformin in treatment of non-insulin-dependent diabetes mellitus. Endocr Pract (Sep), 4(5): 259-267.
Professional Memberships:
- Association of Program Directors in Endocrinology and Metabolism (2009–present)
- American Association of Clinical Endocrinologists; Member (2005–present)
- American Diabetes Association; Member (2001–present)
- Endocrine Society; Member (2001–present)
- American Medical Association; Member
- American College of Physicians/American Society of Internal Medicine; Member
Presentations:
- "Management of Hypogonadism in Diabetes and Obesity" American Diabetes Association, 73rd Scientific Session (2013)
- "Symposium on “Effect of Low Testosterone on Glycemic Control and Health in Diabetes and Obesity”" American Diabetes Association, 73rd Scientific Session (2013)
- "Diabetic Ketoacidosis" Invited lecture; IM Residency Program B/SUNY @ Buffalo (2000)
- "Diabetes insipidus and SIADH" Invited lecture; SUNY @ Buffalo; IM Residency Program A & B (1999)
- "GnrH and vascular reactivity" Annual conference; 81st Annual Endocrine Society Meeting (1999)
- "Hypocalcemia and Hypercalcemia" Invited lecture; SUNY@ Buffalo; IM Residency Program A&B (1999)
- "Thyroid function tests" Invited lecture; SUNY @ Buffalo; IM Residency Program A&B (1999)
- "The effect of gender difference and estrogen therapy in vascular reactivity" ; 13th World Congress of Cardiology (1998)
- "Imparied vascular reactivity in non-insulin dependent mellitus" Annual conference; 58th Session of the American Diabetes Association (1998)
- "Advances in treatment of diabetes mellitus" Invited lecture; Broks Memorial Hospital; Diabetes Supprt Group (1997)
- "Current research in diabetes mellitus" Invited lecture; MFH/Gates Circle; Diabetes Supprt Group (1997)
- "Diabetes mellitus in pregnancy" Invited lecture; SUNY @ Buffalo; Dept. of Pharmacy (1997)
- "Impaired vascular reactivity in non-insulin dependent diabetes mellitus" Invited lecture; Eastern Great Lakes Endocrine Society Meeting (1997)
- "Insulin-induced vasodilationn of internal carotid artery" Annual conference; 46th Session of the American College of Cardiology (1997)
- "Insulin-induced venodilation is further impaired in type 11 diabetes mellitus with hypercholesterlemia" Annual conference; 16th International Diabetes Federation Congress (1997)
- "Pituitary disorders" Invited lecture; D'Youville; Physician Assistant Program (1997)
- "Plasma TGF-B1 in diabetes mellitus" Annual conference; 79th Annual Endocrine Society Meeting (1997)
- "The combination of insulin and metformin in the treatment of NIDDM" International conference; 16th International Diabetes Federation Congress (1997)
- "The combination of insulin and metformin in the treatment of NIDDM" Annual conference; 57th Scientific Session, American Diabetes Association (1997)
- "Diabetes and insuling-resistant states" Invited lecture; SUNY @ Buffalo; Cardiopulmonary group (1996)
- "Medical management of diabetes" Invited lecture; SUNY @ Buffalo; Dept. of Nutrition (1996)
- "Serum TNF a increases follwing glucose challenge in the obese" International Meeting; 10th International Congress of Endocrinology (1996)
- "The effect of glucocorticoids on oxygen reactive species generation: Possible involvement of NFkB/1kB transcription factors" Annual meeting; Eastern Great Lakes Endocrine Meeting (1996)
- "Vascular reactivity in insulin-resistant states" Invited lecture; Millard Fillmore Hospital; Interdisciplinary Vascular Research Group (1996)
- "“Hyperglycemia in hospitalized patients”: Rationale for INTENSIVE Trial" Metabolic Education summit
- "“Impact of Hyperglycemia and Insulin in Acute Coronary syndromes”" Annual Cardiovascular Update, Advocate Health System
- "Benefits of insulin Therapy" 41st Annual Kilo Diabetes Symposium
- "Beta Cell Dysfunction: Science of Insulin therapy" Second Annual Cardio Metabolic Health Congress; Second Annual Cardio Metabolic Health Congress
- "Diabetes and Cardiovascular Disease" Annual Endocrine Society Meeting; Annual Endocrine Society Meeting
- "Impact of Hyperglycemia and Insulin in Acute Coronary Syndromes" Grand Rounds; Fairview Hospital
- "Impact of Hyperglycemia and Insulin in CABG patients" Cardiothoracic Surgery Grand rounds; Westchester Medical Center
- "Impact of Hyperglycemia on Acute Coronary Syndromes" Annual Endocrine Society Meeting; Annual Endocrine Society Meeting; CME symposium
- "Impact of Hyperglycemia on the Vessel Wall" Vascular Biology Working Group Regional Adjunct Faculty CME symposium
- "Impact of Hyperglycemia on the Vessel Wall" Vascular Biology Working Group Regional Adjunct Faculty CME symposium
- "Impact of Hyperglycemia on the Vessel Wall" Vascular Biology Working Group Regional Adjunct Faculty CME symposium
- "Impact of Hyperglycemia on the Vessel Wall" Vascular Biology Working Group Online CME web cast
- "Impact of Hyperglycemia on Vascular Disease" Cardiology Grand rounds; Westmoreland Hospital
- "Insulin use in hospitalized patients" Baystate Medical Center; Baystate Medical Center
- "Management of Diabetes in the Elderly" Annual Meeting of American Director’s Medical Association
- "Management of Diabetes in the Elderly" Mid-Year American Society of Consultant Pharmacists Meeting
- "Patient Case Seminar on the Impact of Hyperglycemia on Acute Coronary Syndromes" Vascular Biology Working Group Faculty CME symposium
- "Patient Case Seminar on the Impact of Hyperglycemia on Acute Coronary Syndromes" Vascular Biology Working Group Faculty CME symposium
Service Activities:
- Member of Promotions Committee Member of Promotions Committee (non-tenured) (2016- present); Committee Member (2016–present)
- Judge for the Annual Department of Medicine Research Day Judge for the Annual Department of Medicine Research Day (2014); Judge (2014)
- Raine Foundation Raine Foundation (University of Western Australia) (2014); Reviewer (2014)
- Quality Committee of OPA Quality Committee of OPA (2014 to present); Co-Chair (2014–present)
- Member of Gastrointestinal Chief Search Committee Member of Gastrointestinal Chief Search Committee. (2014 to present); Committee Member (2014–present)
- Healthy U presentation on Diabetes Management Healthy U presentation on Diabetes Management at Millard Filmore Suburban 2014; Presentor (2014–present)
- Skolkovo Foundation Skolkovo Foundation, Russia (2013); Reviewer (2013)
- National Association of Neuroendocrine Tumor Society National Association of Neuroendocrine Tumor Society (2013); Faculty Liaison (2013)
- Member of SUNY at Buffalo, Faculty council Member of SUNY at Buffalo, Faculty council (2013 to present); Councilor (2013–present)
- Diabetes Management Editorial Board 2013 to Present; Editorial Board Member (2013–present)
- Board for Telemedicine for Gowanda Rehabilitation Center Board for Telemedicine for Gowanda Rehabilitation Center (2013 to present); Member (2013–present)
- Diabetes Diabetes (2013 to present); Reviewer (2013–present)
- Journal of American College of Cardiology Journal of American College of Cardiology (2013 to present); Reviewer (2013–present)
- Journal of Diabetes and its complications Journal of Diabetes and its complications (2013 to present); Reviewer (2013–present)
- Value Proposition Committee of OPA Value Proposition Committee of OPA (2012 to 2013); Co-Chair (2012–2013)
- WGRZ 2 Healthy Zone Television Show on Diabetes 2012 and 2013 WGRZ 2 Healthy Zone Television Show on Diabetes 2012 and 2013; Organizing Committee Member (2012–2013)
- Member of Program Directors Advisory Committee Member of Program Directors Advisory Committee (2012 to present); Advisory Committee (2012–present)
- Novo Nordisk Novo Nordisk (2012 to present); Consultant (2012–present)
- Physician Leadership Board of Optimum Physician Alliance (OPA) Physician Leadership Board of Optimum Physician Alliance (OPA) – a physician network with Kaleida Health / Health Now (2012 to present); Member (2012–present)
- Pfizer Pfizer (2011); Consultant (2011–present)
- Bristol Myer Squibbs Bristol Myer Squibbs (2011); Consultant (2011–present)
- Diabetes Endocrinology Center of Kaleida Health Diabetes Endocrinology Center of Kaleida Health (2011-present); Director (2011–present)
- Lilly Lilly (2010 to present); Consultant (2010–present)
- Joint Commission Journal on Quality and Patient Safety Joint Commission Journal on Quality and Patient Safety (2009); Reviewer (2009)
- National Kidney Foundation National Kidney Foundation (2007 to 2011); Faculty Liaison (2007–2011)
- Vascular Biology Working Group Vascular Biology Working Group (2007 to 2009); Faculty Liaison (2007–2009)
- Taught in a Diabetes Management CME course for Physicians in Egypt Taught in a Diabetes Management CME course for Physicians in Egypt (2007); Teacher (2007)
- Sanofi –Aventis Sanofi –Aventis (2007 to present); Consultant (2007–present)
- Diabetes Care Diabetes Care (2007 to present); Reviewer (2007–present)
- Program Director, SUNY at Buffalo Endocrinology Fellowship Program Program Director, SUNY at Buffalo Endocrinology Fellowship Program (2005 to present); Director (2005–present)
- Metabolic Syndrome and Related Disorders Editorial Board 2005 to Present; Editorial Board Member (2005–present)
- Journal of PostGraduate Medicine Journal of PostGraduate Medicine (2010 to present); Reviewer (2005–present)
- Quality Team of Millard Fillmore Gates to improve Glycemic control in Hospitalized patients. Quality Team of Millard Fillmore Gates to improve Glycemic control in Hospitalized patients. Developed ICU IV insulin protocol and non critical care SC insulin protocols in Kaleida health. (2004 to 2005); Member (2004–2005)
- MetabolicSyndrome and Related Disorders MetabolicSyndrome and Related Disorders (2004 to present); Reviewer (2004–present)
- Free Radical Medicine and Biology Free Radical Medicine and Biology (2005 to present); Reviewer (2004–present)
- Training of endocrinology fellows Training of endocrinology fellows associated with the SUNY at Buffalo Endocrinology Fellowship program. (34 fellows have graduated) 2000-present.; Teacher (2000–present)
- Endocrine lecture series for endocrine fellows Endocrine lecture series for endocrine fellows, internal medicine residents, lectures and presentations at grand rounds for internal medicine and family medicine residents in SUNY at Buffalo, Catholic System and Niagara Falls DO programs (Average one lecture every month) 2000- present.; Teacher (2000–present)
- Training of internal medicine, family medicine gynecology and obstetrics residents, physician assistant , nurse practitioner and medical students Training of internal medicine, family medicine gynecology and obstetrics residents, physician assistant , nurse practitioner and medical students rotating through the Diabetes and Endocrinology Center. (Average three residents and two students per month) 2000- present.; Teacher (2000–present)
- Teaching the Endocrine module for medical students from the University of Buffalo Medical School Teaching the Endocrine module for medical students from the University of Buffalo Medical School. (Average 8 hrs a year) 2000- present.; Teacher (2000–present)
- Community Leadership Board, American Diabetes Association, Buffalo Community Leadership Board, American Diabetes Association, Buffalo; President